Subsidiary
Yantai Valiant Pharmaceutical Co., Ltd.
Valiant Pharmaceutical was established in 2012 with a register capital of CNY 75 million and total investment of 200 million. It mainly engages in R&D, production and sales of APIs, oral solid preparation and health food.

Valiant Pharma. covers an area of 56500㎡and with floor area of 24000㎡. There are currently 280 employees in total. It is equipped with GMP certificated synthesis workshop, oral solid preparation workshop, traditional Chinese medicine extraction workshop and oral liquid preparation workshop.

There are dozens of high educated R&D personnel who work closely with domestic and foreign universities, scientific research institutes in the development of innovator drugs.

Our APIs have gradually entered domestic market and some of them have passed PMDA and obtained foreign pharmaceutical manufacturers’ certificate. We also work closely with customers from Euro and North America to jointly develop APIs, our aim is to pass WHO, EMA in order to explore the EU & US market.

The pharmaceutical product Norfloxacin Capsule took the lead in passing the consistency evaluation of the quality and efficacy of domestic Generic drugs in December 2019.

Web: http://www.wanrunyaoye.com/
About | Privacy | Contact
Copyright © 2012 Valiant Co., Ltd. All Rights Reserved